- Our Story
- Our Products
- Our Science
- Our People & Citizenship
-
Investors
- Reports and Filings
- Presentations & Earnings Calls
-
Shares
- Share Price
- Stock Updates
- Equity & Dividend History
- Unpaid & Unclaimed Dividend
- Analyst Coverage
- Shareholding Pattern
- Share Transfer Information
- Buyback
- Details of Shares for transfer to IEPF May 2018
- Notice pursuant to IEPF Rules, May 2018
- Details of Shares for transfer to IEPF May 2019
- Notice Pursuant to IEPF Rules, May 2019
- Details of Shares for transfer to IEPF May 2020
- Notice pursuant to IEPF Rules, May 2020
- Details of Shares for transfer to IEPF May 2021
- Notice pursuant to IEPF Rules, May 2021
- Governance
- Investor Services
-
ESG profile
- Media
- Partners
- Contact Us
Dr. Reddy's in the news
-
13 Indian firms set to boost India's anti-Covid arsenal with a pill
Click Here for the Complete Story [PDF Format] -
Dr Reddy's Laboratories to introduce Molnupiravir to treat COVID-19 shortly
Click Here for the Complete Story [PDF Format] -
Dr Reddy labs get DCGI approval to manfacture & market anti-viral drug 'Molnupiravir'
Click Here for the Complete Story [PDF Format] -
Dr Reddy's gets DCGI nod for Molnupiravir, to launch soon
Click Here for the Complete Story [PDF Format] -
Dr Reddy's Laboratories to introduce Molnupiravir to treat Covid-19 shortly
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s, Strides Pharma shares rally on DCGI approval for COVID-19 drug
Click Here for the Complete Story [PDF Format] -
Fuelling pharma innovation: Govt’s draft R&D policy a welcome, inclusive step forward
Click Here for the Complete Story [PDF Format] -
Pharma, healthcare industry looks to sustain momentum in 2022
Click Here for the Complete Story [PDF Format] -
Evolving Role of Pharma CFOs – Business Strategist, Leader and Advisor | Industry Knowledge Exchange Forum
Click Here for the Complete Story [PDF Format] -
Closing Bell: Last hour recovery offffsets some loss as Sensex, Nifty end 2% lower – Cipla, HUL, Dr Reddy's only gainers
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s Lab become Most Innovative Company of india in 8th Industrial Innovation Awards
Click Here for the Complete Story [PDF Format] -
CII felicitates Top Innovative Companies and Research Institutions of 2021 at the DST-CII Technology Summit
Click Here for the Complete Story [PDF Format] -
DST-CII tech summit recognizes industrial innovations having potential to create a paradigm shift at the 8th Industrial Innovation Award
Click Here for the Complete Story [PDF Format] -
Buy Dr. Reddy's Laboratories, target price Rs 5525: Emkay Global
Click Here for the Complete Story [PDF Format] -
Dr. Reddy's receives approval for VeraRing from USFDA
Click Here for the Complete Story [PDF Format] -
DRL'S VeraRing gets FDA nod
Click Here for the Complete Story [PDF Format] -
Dr Reddy's launches drug in US to treat high blood pressure, heart failure
Click Here for the Complete Story [PDF Format] -
Dr Reddys, Prestige BioPharma Ink Pact For Trastuzumab Biosimilar Commercialization In Select Countries
Click Here for the Complete Story [PDF Format] -
Dr Reddy's, Prestige BioPharma partner to commercialise Trastuzumab biosimilar for cancer treatment
Click Here for the Complete Story [PDF Format] -
Dr Reddy's Labs launches Valsartan tablets in US market
Click Here for the Complete Story [PDF Format] -
Dr. Reddy's inks pact with Singapore firm Prestige BioPharma to commercialise Trastuzumab biosimilar in select countries
Click Here for the Complete Story [PDF Format] -
Dr Reddy's launches drug in US to treat high blood pressure, heart failure
Click Here for the Complete Story [PDF Format] -
Prestige BioPharma and Dr. Reddy's announce exclusive partnership
Click Here for the Complete Story [PDF Format] -
Prestige BioPharma and Dr Reddys form partnership
Click Here for the Complete Story [PDF Format] -
Several partners for the production of Sputnik Light
Click Here for the Complete Story [PDF Format] -
Vaccination the best protection against "omicron" and other strains of coronavirus
Click Here for the Complete Story [PDF Format] -
Pfizer and Merck Covid-19 Pills Are Coming Soon in the U.S., but Other Countries Will Have to Wait
Click Here for the Complete Story [PDF Format] -
PLI scheme for pharma to benefit 55 firms, says Centre
Click Here for the Complete Story [PDF Format] -
Centre of excellence on flow chemistry to come up in Hyderabad
Click Here for the Complete Story [PDF Format] -
Buy Dr. Reddy's Laboratories, target price Rs 4730: Kotak Securities
Click Here for the Complete Story [PDF Format] -
Telangana to set up CoE in flow chemistry
Click Here for the Complete Story [PDF Format] -
As focus shifts to Covid pills, Indian companies eye affordable antiviral medicine
Click Here for the Complete Story [PDF Format] -
Funding push to pharma R&D critical for unleashing next phase of growth
Click Here for the Complete Story [PDF Format] -
Indian pharma CEOs bet big on innovation to achieve US $130 bn
Click Here for the Complete Story [PDF Format] -
India's Dr. Reddy's open to making Pfizer COVID pill after Merck deal
Click Here for the Complete Story [PDF Format] -
Experts deliberate on enhancing culture of research in India on concluding day of Global Innovation Summit-2021
Click Here for the Complete Story [PDF Format] -
Sun Pharma, other drug cos say innovative products to contribute substantially in future
Click Here for the Complete Story [PDF Format] -
Without innovation Indian pharma cannot touch $130 bn by 2030: Industry
Click Here for the Complete Story [PDF Format] -
Pharma infra: Gearing for new realities
Click Here for the Complete Story [PDF Format] -
Sputnik Light has a high safety profile
Click Here for the Complete Story [PDF Format] -
B-Ingelheim India Chief On Strategy, Jardiance Challenge, Gender Balance In Pharma
Click Here for the Complete Story [PDF Format] -
CareerLabs partners with Dr. Reddys for chemical engineering certification programme
Click Here for the Complete Story [PDF Format] -
Dr Reddys Gears For Sputnik Pediatric Shot, Molnupiravir Upside
Click Here for the Complete Story [PDF Format] -
Dr Reddys Laboratories Q2 net profit up 30% at ₹992 crore
Click Here for the Complete Story [PDF Format] -
Dr Reddys Laboratories Q2 net profit up 30% at ₹992 crore
Click Here for the Complete Story [PDF Format] -
Dr Reddys aiming to create its own space in vaccine segment
Click Here for the Complete Story [PDF Format] -
Dr. Reddys Q2 results_ Consolidated PAT rises 30% YoY, beats estimate - The Economic Times
Click Here for the Complete Story [PDF Format] -
Dr. Reddys Expected to Submit Sputnik V Light Trial Data to DCGI in November
Click Here for the Complete Story [PDF Format] -
Dr. Reddys gets FDA nod for generic Revlimid; enjoys 180 days exclusivity - The Economic Times
Click Here for the Complete Story [PDF Format] -
Dr. Reddys Laboratories Announces the Launch of Ephedrine Sulfate Injection USP, 50 mg_mL, Single-Dose Vial in the U.S. Market
Click Here for the Complete Story [PDF Format] -
Dr. Reddys Labs gains 7% as profit grows 30% YoY in Q2, margins expand
Click Here for the Complete Story [PDF Format] -
Dr. Reddys Q2 net profit up 30% to Rs 992 cr on robust sales
Click Here for the Complete Story [PDF Format] -
Dr. Reddys Q2 profit rises 30% to ₹992 cr; stock up 6%
Click Here for the Complete Story [PDF Format] -
Dr. Reddys to seek nod for Sputnik Light - Times of India
Click Here for the Complete Story [PDF Format] -
Need to standardise pandemic best practices_ PM Modi to vaccine companies - Times of India
Click Here for the Complete Story [PDF Format] -
PM interacts with domestic vaccine manufacturers
Click Here for the Complete Story [PDF Format] -
Success Story for Aatmanirbhar Bharat, Cheapest Covid-19 Vaccines in World_ Vaccine Makers Laud PM Modi
Click Here for the Complete Story [PDF Format] -
Vaccine makers played big role in India's success story_ PM Modi
Click Here for the Complete Story [PDF Format] -
World is a CEO oyster for India inc.
Click Here for the Complete Story [PDF Format] -
Internal Audit - the Silent Value Enhancer
Click Here for the Complete Story [PDF Format] -
Single-dose Sputnik Light shows 70% efficacy against Delta variant
Click Here for the Complete Story [PDF Format] -
COVID-19 vaccine: Govt allows export of Russia's Sputnik Light made in India
Click Here for the Complete Story [PDF Format] -
Indian pharm requires a fresh approach, strategic investments and outcome-specific thinking
Click Here for the Complete Story [PDF Format] -
Russia sees no hurdles for WHO approval of Sputnik V vaccine
Click Here for the Complete Story [PDF Format] -
Russia sees no hurdles for WHO approval of Sputnik V vaccine
Click Here for the Complete Story [PDF Format] -
Dr Reddy's sets Guinness record title with 'Fastminar'
Click Here for the Complete Story [PDF Format] -
Dr Reddy's brushes way into Guinness World Records with largest toothbrush sculpture of tooth
Click Here for the Complete Story [PDF Format] -
Dr Reddy's sets Guinness Record with largest toothbrush sculpture in Navi Mumbai
Click Here for the Complete Story [PDF Format] -
Dr. Reddy''s sets Guinness Record with largest toothbrush sculpture in Navi Mumbai
Click Here for the Complete Story [PDF Format] -
Why you should accumulate Dr. Reddy's Lab shares
Click Here for the Complete Story [PDF Format] -
Dr Reddy's aiming to create its own space in vaccine segment:GV Prasad
Click Here for the Complete Story [PDF Format] -
Threat of 3rd wave of COVID19: Are you armoured with 2nd shot of COVID19 vaccine?
Click Here for the Complete Story [PDF Format] -
CareerLabs Partners With Dr Reddy For Chemical Engineering Certification Programme
Click Here for the Complete Story [PDF Format] -
Express Pharma and Ansys organise virtual summit on accelerating process scale-up with simulation
Click Here for the Complete Story [PDF Format] -
Announcing collaboration with the Forest Department, Medchal Disctrict, Government of Telangana
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s Labs gets approval for phase 3 trials of Sputnik Light in India
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s gets drug regulator's nod for Phase III bridging trials of Sputnik Light covid vaccine
Click Here for the Complete Story [PDF Format] -
Sputnik's single-dose vax gets DCGI nod for Phase-III trials in India
Click Here for the Complete Story [PDF Format] -
Redefining job roles to build competitive compliance
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s move to exit some proprietary drugs has benefits
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s starts supply of Sputnik V first doses
Click Here for the Complete Story [PDF Format] -
Dr Reddy''s launches Minoxidil for treatment of female pattern hair loss in India
Click Here for the Complete Story [PDF Format] -
Dr. Reddy’s launches Minoxidil drug for treatment of female pattern hair loss
Click Here for the Complete Story [PDF Format] -
Dr Reddy's launches cancer drug in Canada
Click Here for the Complete Story [PDF Format] -
Dr Reddy's to sell its rights of anti-cancer agent to Citius Pharma
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s to sell its rights of anti-cancer agent to Citius Pharma
Click Here for the Complete Story [PDF Format] -
Chunk of Telangana's dengue cases undetected: Public Health Foundation of India chief
Click Here for the Complete Story [PDF Format] -
Indonesia approves Sputnik V for emergency use
Click Here for the Complete Story [PDF Format] -
Despite engineering being a passion, how and why she chose to enter HR world, HR News, ETHRWorld
Click Here for the Complete Story [PDF Format] -
Dr Reddy's Gears For Sputnik Light In India, Jab For Adolescents
Click Here for the Complete Story [PDF Format] -
Indian pharma industry to touch $130 bn by 2030: Dr Reddy's chairman
Click Here for the Complete Story [PDF Format] -
Dr Reddy's SVAAS Wellness partners with ICICI Lombard
Click Here for the Complete Story [PDF Format] -
Dr Reddy's SVAAS Wellness partners with ICICI Lombard
Click Here for the Complete Story [PDF Format] -
Indian pharmaceutical industry to cross Rs 96,000 cr by 2030, says chairman of Dr Reddy's Laboratories
Click Here for the Complete Story [PDF Format] -
Nifty Pharma tops 180 pts ahead of Sun Pharma Q1 earnings; Alkem, Cadila, Dr Reddy's in the fast lane
Click Here for the Complete Story [PDF Format] -
Made-in-India Sputnik V to be available by Oct: Dr. Reddy's
Click Here for the Complete Story [PDF Format] -
Indian pharmaceutical industry to touch $130 billion by 2030 Dr Reddy's chairman K Satish Reddy
Click Here for the Complete Story [PDF Format] -
Working with RDIF to ramp up Sputnik supplies: Dr. Reddy's
Click Here for the Complete Story [PDF Format] -
Dr Reddy's floats wholly-owned arm for digital health soluons
Click Here for the Complete Story [PDF Format] -
Dr Reddy's jusfies 2DG price of ₹990 per sachet
Click Here for the Complete Story [PDF Format] -
Anti-Covid drug 2DG good, but timing is crucial: Investigator
Click Here for the Complete Story [PDF Format] -
Assam: Sputnik V preferred jab for shorter gap between doses
Click Here for the Complete Story [PDF Format] -
Wockhardt Hospital, Mumbai Central Kickstarts Sputnik V Jabs
Click Here for the Complete Story [PDF Format] -
How Dr Reddy's is making the most of its opportunities
Click Here for the Complete Story [PDF Format] -
Sputnik V Doses For Transgenders In Bengaluru Vaccine Drive
Click Here for the Complete Story [PDF Format] -
Sputnik V records 97.8% efficacy against Covid-19 in UAE, fully effective against severe cases
Click Here for the Complete Story [PDF Format] -
B Medical Systems joins hands with Dr Reddy’s for pan-India rollout of Sputnik V vaccines
Click Here for the Complete Story [PDF Format] -
Covid-19: Dr Reddy's, Cipla, 3 more pharma firms partner for clinical trial of oral anti-viral drug
Click Here for the Complete Story [PDF Format] -
Dr Reddy’s Labs announces commercial launch of 2-DG
Click Here for the Complete Story [PDF Format] -
Dr Reddy's Laboratories launches Icosapent Ethyl Capsules in US
Click Here for the Complete Story [PDF Format] -
Dr Reddy's launches generic version of triglyceride lowering drug Vascepa in US
Click Here for the Complete Story [PDF Format] -
Sputnik V vaccine protects from all known variants of Covid: Head of Russia's Gamaleya Institute
Click Here for the Complete Story [PDF Format] -
Aster DM Healthcare partners with Dr Reddy's to administer Sputnik V vaccine in select locations
Click Here for the Complete Story [PDF Format] -
Sputnik V more effcient against Delta strain of COVID-19 compared to any other jab: RDIF
Click Here for the Complete Story [PDF Format] -
Sputnik V vaccine makes debut in Mumbai as part of pilot project
Click Here for the Complete Story [PDF Format] -
Access to DRDO drug 2-DG will improve in weeks: Dr.Reddy's
Click Here for the Complete Story [PDF Format] -
Sputnik V debuts in Kolkata, 150 get jabs
Click Here for the Complete Story [PDF Format] -
DRDO issues directions on usage of anti-COVID drug 2-DG
Click Here for the Complete Story [PDF Format] -
Single-dose Sputnik Light could be first single-dose vaccine launched in India
Click Here for the Complete Story [PDF Format] -
Not authorised any 3rd party to supply Sputnik V in India, legal action against unscrupulous elements: Dr Reddy's & RDIF
Click Here for the Complete Story [PDF Format] -
Dr Reddy's administers first dose of Sputnik V vaccine, imported doses at RS 995/jab
Click Here for the Complete Story [PDF Format] -
Dr Reddy's is not as big in India as it should be. We want to grow more.
Click Here for the Complete Story [PDF Format] -
Why a New Expat CEO may be Good News for Dr Reddy's
Click Here for the Complete Story [PDF Format] -
Indian Pharma Industry: From cultural practices to being quality-intensive
Click Here for the Complete Story [PDF Format]
